These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 26039021)
1. [Emotional and language prosody and working memory in patients with depression]. Talarowska M; Zajączkowska M; Gałecki P Pol Merkur Lekarski; 2015 May; 38(227):269-72. PubMed ID: 26039021 [TBL] [Abstract][Full Text] [Related]
2. Thiol protein groups correlate with cognitive impairment in patients with recurrent depressive disorder. Gałecki P; Talarowska M; Bobińska K; Kowalczyk E; Gałecka E; Lewiński A Neuro Endocrinol Lett; 2013; 34(8):780-6. PubMed ID: 24522026 [TBL] [Abstract][Full Text] [Related]
3. Nitric oxide plasma concentration associated with cognitive impairment in patients with recurrent depressive disorder. Talarowska M; Gałecki P; Maes M; Orzechowska A; Chamielec M; Bartosz G; Kowalczyk E Neurosci Lett; 2012 Feb; 510(2):127-31. PubMed ID: 22273980 [TBL] [Abstract][Full Text] [Related]
4. Cognitive functions in first-episode depression and recurrent depressive disorder. Talarowska M; Zajączkowska M; Gałecki P Psychiatr Danub; 2015 Mar; 27(1):38-43. PubMed ID: 25751430 [TBL] [Abstract][Full Text] [Related]
5. Auditory-verbal declarative and operating memory among patients suffering from depressive disorders - preliminary study. Talarowska M; Florkowski A; Zboralski K; Berent D; Wierzbiński P; Gałecki P Adv Med Sci; 2010; 55(2):317-27. PubMed ID: 21163755 [TBL] [Abstract][Full Text] [Related]
6. Manganese superoxide dismutase gene expression and cognitive functions in recurrent depressive disorder. Talarowska M; Orzechowska A; Szemraj J; Su KP; Maes M; Gałecki P Neuropsychobiology; 2014; 70(1):23-8. PubMed ID: 25171019 [TBL] [Abstract][Full Text] [Related]
7. Cognitive inhibition and working memory in unipolar depression. Gohier B; Ferracci L; Surguladze SA; Lawrence E; El Hage W; Kefi MZ; Allain P; Garre JB; Le Gall D J Affect Disord; 2009 Jul; 116(1-2):100-5. PubMed ID: 19042027 [TBL] [Abstract][Full Text] [Related]
8. Malondialdehyde plasma concentration correlates with declarative and working memory in patients with recurrent depressive disorder. Talarowska M; Gałecki P; Maes M; Gardner A; Chamielec M; Orzechowska A; Bobińska K; Kowalczyk E Mol Biol Rep; 2012 May; 39(5):5359-66. PubMed ID: 22170602 [TBL] [Abstract][Full Text] [Related]
9. Working memory as a predictor of negative symptoms and functional outcome in first episode psychosis. González-Ortega I; de Los Mozos V; Echeburúa E; Mezo M; Besga A; Ruiz de Azúa S; González-Pinto A; Gutierrez M; Zorrilla I; González-Pinto A Psychiatry Res; 2013 Mar; 206(1):8-16. PubMed ID: 22985548 [TBL] [Abstract][Full Text] [Related]
10. Myeloperoxidase gene expression and cognitive functions in depression. Talarowska M; Szemraj J; Gałecki P Adv Med Sci; 2015 Mar; 60(1):1-5. PubMed ID: 25038328 [TBL] [Abstract][Full Text] [Related]
11. Working memory impairment as a common component in recurrent depressive disorder and certain somatic diseases. Galecki P; Talarowska M; Moczulski D; Bobinska K; Opuchlik K; Galecka E; Florkowski A; Lewinski A Neuro Endocrinol Lett; 2013; 34(5):436-45. PubMed ID: 23922050 [TBL] [Abstract][Full Text] [Related]
12. The reliability and convergent and divergent validity of the Ruff Figural Fluency Test in healthy young adults. Ross TP Arch Clin Neuropsychol; 2014 Dec; 29(8):806-17. PubMed ID: 25314955 [TBL] [Abstract][Full Text] [Related]
13. fMRI delineation of working memory for emotional prosody in the brain: commonalities with the lexico-semantic emotion network. Mitchell RL Neuroimage; 2007 Jul; 36(3):1015-25. PubMed ID: 17481919 [TBL] [Abstract][Full Text] [Related]
14. Relationship of affect recognition with psychopathology and cognitive performance in schizophrenia. Bozikas VP; Kosmidis MH; Anezoulaki D; Giannakou M; Karavatos A J Int Neuropsychol Soc; 2004 Jul; 10(4):549-58. PubMed ID: 15327733 [TBL] [Abstract][Full Text] [Related]
15. [Correlations between working memory effectiveness and depression levels after pharmacological therapy]. Talarowska M; Zboralski K; Gałecki P Psychiatr Pol; 2013; 47(2):255-67. PubMed ID: 23888759 [TBL] [Abstract][Full Text] [Related]